Featured
2012 President's Message
In "The Push for the Summit: Creating Health Care's New Terrain," we now set our sights on frontiers and summits yet to come.
You are now viewing 1 - 1 of 1 results
September 1, 2008 | Commentary
An intensified focus on drug safety often leads to demands for more data collection prior to drug approval. Increased post-marketing surveillance can also play an important role, but the optimal approach must be chosen for each case as it arises.